Abstract
In response to DNA damage, the cell cycle checkpoint is an important biological event in maintaining genomic fidelity. Gadd45, a p53-regulated and DNA damage inducible protein, has recently been demonstrated to play a role in the G2-M checkpoint in response to DNA damage. In the current study, we further investigated the biochemical mechanism(s) involved in the GADD45-activated cell cycle G2-M arrest. Using the tetracycline-controlled system (tet-off), we established GADD45-inducible lines in HCT116 (wild-type p53) and Hela (inactivated p53 status) cells. Following inducible expression of the Gadd45 protein, cell growth was strongly suppressed in both HCT116 and Hela cells. Interestingly, HCT116 cells revealed a significant G2-M arrest but Hela cells failed to arrest at the G2-M phases, indicating that the GADD45-activated G2-M arrest requires normal p53 function. The GADD45-induced G2-M arrest was observed independent of p38 kinase activity. Importantly, induction of Gadd45 protein resulted in a reduction of nuclear cyclin B1 protein, whose nuclear localization is critical for the completion of G2-M transition. The reduced nuclear cyclin B1 levels correlated with inhibition of Cdc2/cyclin B1 kinase activity. Additionally, overexpression of cyclin B1 substantially abrogated the GADD45-induced cell growth suppression. Therefore, GADD45 inhibition of Cdc2 kinase activity through alteration of cyclin B1 subcellular localization may be an essential step in the GADD45-induced cell cycle G2-M arrest and growth suppression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agarwal ML, Agarwal A, Taylor WR, Stark GR . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497
Bernhard EJ, Maity A, Muschel RJ, McKenna WG . 1995 Radiat. Environ. Biophys. 34: 79–83
Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, Appella E, Fornace Jr AJ . 2001 Nature 411: 102–107
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . 1998 Science 282: 1497–1501
Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B . 1999 J. Clin. Invest. 104: 263–269
Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, Fornace Jr AJ . 1999 Mol. Cell. Biol. 19: 1673–1685
Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace Jr AJ, O'Connor PM . 1996 Oncogene 12: 595–607
Ducommun B, Brambilla P, Felix MA, Franza Jr BR, Karsenti E, Draetta G . 1991 EMBO J. 10: 3311–3319
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Elledge SJ . 1996 Science 274: 1664–1672
Fornace Jr AJ, Alamo Jr I, Hollander MC . 1988 Proc Natl Acad Sci USA 85: 8800–8804
Fornace Jr AJ, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ . 1989 Mol. Cell. Biol. 9: 4196–4203
Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS . 1995 Oncogene 10: 2427–2433
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816
Hartwell LH, Kastan MB . 1994 Science 266: 1821–1828
Hartwell LH, Weinert TA . 1989 Science 246: 629–634
Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B . 1997 Mol. Cell 1: 3–11
Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace Jr AJ . 1999 Nat. Genet. 23: 176–184
Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace Jr AJ, Zhan Q . 2000 J. Biol. Chem. 275: 16602–16608
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW . 1991 Cancer Res. 51: 6304–6311
Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597
Kearsey JM, Coates PJ, Prescott AR, Warbrick E, Hall PA . 1995 Oncogene 11: 1675–1683
Kohn KW, Jackman J, O'Connor PM . 1994 J Cell Biochem 54: 440–452
Muschel RJ, Zhang HB, Iliakis G, McKenna WG . 1991 Cancer Res. 51: 5113–5117
Muschel RJ, Zhang HB, Iliakis G, McKenna WG . 1992 Radiat Res 132: 153–157
O'Connor PM . 1997 Cancer Surv. 29: 151–182
O'Connor PM, Fan S . 1996 Prog. Cell Cycle Res. 2: 165–173
O'Connor PM, Kohn KW . 1992 Semin. Cancer Biol. 3: 409–416
Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo Jr I, Barrett SF, Hickson ID, Fornace Jr AJ . 1991 Mol. Cell. Biol. 11: 1009–1016
Paulovich AG, Toczyski DP, Hartwell LH . 1997 Cell 88: 315–321
Sherr CJ, Roberts JM . 1995 Genes Dev. 9: 1149–1163
Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace Jr AJ . 1994 Science 266: 1376–1380
Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L . 2000 Cancer Res. 60: 4000–4004
Stewart N, Hicks GG, Paraskevas F, Mowat M . 1995 Oncogene 10: 109–115
Takekawa M, Saito H . 1998 Cell 95: 521–530
Thompson DA, Belinsky G, Chang TH, Jones DL, Schlegel R, Munger K . 1997 Oncogene 15: 3025–3035
Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E . 1998 EMBO J. 17: 2728–2735
Waldman T, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5187–5190
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC . 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . 1993 Nature 366: 701–704
Yu M, Zhan Q, Finn OJ . 2002 Mol. Immunology 38: 981–987
Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace Jr AJ . 1999 Oncogene 18: 2892–2900
Zhan Q, Bae I, Kastan MB, Fornace Jr AJ . 1994a Cancer Res. 54: 2755–2760
Zhan Q, Chen IT, Antinore MJ, Fornace Jr AJ . 1998 Mol. Cell Biol. 18: 2768–2778
Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo Jr I, O'Connor PM, Fornace Jr AJ . 1996 DNA Cell Biol. 15: 805–815
Zhan Q, Lord KA, Alamo Jr I, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace Jr AJ . 1994b Mol. Cell Biol. 14: 2361–2371
Zhang H, Hannon GJ, Casso D, Beach D . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 21–29
Zhao H, Jin S, Antinore MJ, Lung FD, Fan F, Blanck P, Roller P, Fornace Jr AJ, Zhan Q . 2000 Exp. Cell. Res. 258: 92–100
Acknowledgements
This study was supported in part by National Institutes of Health Grant R01 CA-83874.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jin, S., Tong, T., Fan, W. et al. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 21, 8696–8704 (2002). https://doi.org/10.1038/sj.onc.1206034
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206034
Keywords
This article is cited by
-
FGF19 induces the cell cycle arrest at G2-phase in chondrocytes
Cell Death Discovery (2023)
-
The long noncoding RNA TARID regulates the CXCL3/ERK/MAPK pathway in trophoblasts and is associated with preeclampsia
Reproductive Biology and Endocrinology (2022)
-
Neuroinflammation regulates the balance between hippocampal neuron death and neurogenesis in an ex vivo model of thiamine deficiency
Journal of Neuroinflammation (2022)
-
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Journal of Hematology & Oncology (2021)
-
Gadd45g initiates embryonic stem cell differentiation and inhibits breast cell carcinogenesis
Cell Death Discovery (2021)